Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Parent [Member]
Noncontrolling Interest [Member]
Balance at Oct. 31, 2022 $ 28,200,000 $ 309,000 $ 247,123,000 $ (218,385,000) $ 29,047,000 $ (847,000)
Balance, shares at Oct. 31, 2022   30,913,902        
Stock option compensation to employees and directors 2,112,000 2,112,000 2,112,000
Stock options issued to consultants 128,000 128,000 128,000
Common stock issued upon exercise of stock options 78,000 $ 1,000 77,000 78,000
Common stock issued upon exercise of stock options, shares   29,382        
Common stock issued to consultants 50,000 50,000 50,000
Common stock issued to consultants, shares   13,478        
Common stock issued pursuant to an employee stock purchase plan 6,000 6,000 6,000
Common stock issued pursuant to an employee stock purchase plan   1,903        
Net loss (4,661,000) (4,610,000) (4,610,000) (51,000)
Balance at Apr. 30, 2023 25,913,000 $ 310,000 249,496,000 (222,995,000) 26,811,000 (898,000)
Balance, shares at Apr. 30, 2023   30,958,665        
Balance at Jan. 31, 2023 26,912,000 $ 309,000 248,189,000 (220,707,000) 27,791,000 (879,000)
Balance, shares at Jan. 31, 2023   30,922,830        
Stock option compensation to employees and directors 1,155,000 1,155,000 1,155,000
Stock options issued to consultants 47,000 47,000 47,000
Common stock issued upon exercise of stock options 75,000 $ 1,000 74,000 75,000
Common stock issued upon exercise of stock options, shares   27,818        
Common stock issued to consultants 25,000 25,000 25,000
Common stock issued to consultants, shares   6,114        
Common stock issued pursuant to an employee stock purchase plan 6,000 6,000 6,000
Common stock issued pursuant to an employee stock purchase plan   1,903        
Net loss (2,307,000) (2,288,000) (2,288,000) (19,000)
Balance at Apr. 30, 2023 25,913,000 $ 310,000 249,496,000 (222,995,000) 26,811,000 (898,000)
Balance, shares at Apr. 30, 2023   30,958,665        
Balance at Oct. 31, 2023 23,371,000 $ 311,000 252,222,000 (228,196,000) 24,337,000 (966,000)
Balance, shares at Oct. 31, 2023   31,145,219        
Stock option compensation to employees and directors 2,346,000 2,346,000 2,346,000
Stock options issued to consultants 78,000 78,000 78,000
Common stock issued in an at-the-market offering, net of offering expenses 3,029,000 $ 8,000 3,021,000 3,029,000
Common stock issued in an at- the market offering, net of offering expenses, shares   785,290        
Common stock issued upon exercise of stock options 124,000 124,000 124,000
Common stock issued upon exercise of stock options, shares   43,999        
Common stock issued to consultants 96,000 $ 1,000 95,000 96,000
Common stock issued to consultants, shares   29,336        
Common stock issued pursuant to an employee stock purchase plan 7,000 7,000 7,000
Common stock issued pursuant to an employee stock purchase plan   2,616        
Net loss (6,470,000) (6,394,000) (6,394,000) (76,000)
Balance at Apr. 30, 2024 22,581,000 $ 320,000 257,893,000 (234,590,000) 23,623,000 (1,042,000)
Balance, shares at Apr. 30, 2024   32,006,460        
Balance at Jan. 31, 2024 23,604,000 $ 318,000 255,738,000 (231,451,000) 24,605,000 (1,001,000)
Balance, shares at Jan. 31, 2024   31,754,375        
Stock option compensation to employees and directors 1,238,000 1,238,000 1,238,000
Stock options issued to consultants 22,000 22,000 22,000
Common stock issued in an at-the-market offering, net of offering expenses 833,000 $ 2,000 831,000 833,000
Common stock issued in an at- the market offering, net of offering expenses, shares   229,470        
Common stock issued upon exercise of stock options 57,000 57,000 57,000
Common stock issued upon exercise of stock options, shares   19,999        
Common stock issued pursuant to an employee stock purchase plan 7,000 7,000 7,000
Common stock issued pursuant to an employee stock purchase plan   2,616        
Net loss (3,180,000) (3,139,000) (3,139,000) (41,000)
Balance at Apr. 30, 2024 $ 22,581,000 $ 320,000 $ 257,893,000 $ (234,590,000) $ 23,623,000 $ (1,042,000)
Balance, shares at Apr. 30, 2024   32,006,460